Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.
Ethanol consumption is negatively associated with antiretroviral therapy (ART) adherence and general health in HIV positive individuals. Previously, we demonstrated ethanol-mediated alterations to metabolism of elvitegravir (EVG) in human liver microsomes. In the current study, we investigated ethan...
Main Authors: | Narasimha M Midde, Namita Sinha, Pradeep B Lukka, Bernd Meibohm, Santosh Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5322882?pdf=render |
Similar Items
-
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method.
by: Narasimha M Midde, et al.
Published: (2016-01-01) -
Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages
by: Yuqing Gong, et al.
Published: (2017-12-01) -
A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir
by: Andrea R. Thurman, et al.
Published: (2023-04-01) -
An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia
by: Yuqing Gong, et al.
Published: (2020-05-01) -
Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response
by: Sandip Godse, et al.
Published: (2023-11-01)